Related Experiment Video

Updated: Jul 10, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
09:09

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Hypotension and shock in the preterm infant

Keith J Barrington1

  • 1McGill University, NICU, Royal Victoria Hospital, 687 Pine Ave W, Montréal, Québec H3A 1A1, Canada. keith.barrington@mcgill.ca

Seminars in Fetal & Neonatal Medicine
|November 3, 2007
PubMed

Insights

Hypotension treatment varies widely in preterm infants due to limited evidence. More research is needed to guide interventions for neonatal shock and ensure safe, effective care.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Perinatal Medicine

Background:

  • Significant variation exists in treating hypotension in extremely preterm infants.
  • Lack of reliable evidence hinders the development of standardized treatment protocols.
  • The 'intervention/data imbalance' is pronounced in neonatal hypotension management.

Purpose of the Study:

  • To review the neonatal cardiovascular system's unique characteristics.
  • To define hypotension and shock in preterm infants.
  • To discuss treatment indications and therapies for neonatal hypotension.

Main Methods:

  • Literature review focusing on neonatal hypotension and shock.
  • Analysis of current treatment practices and evidence base.
  • Discussion of diagnostic challenges in assessing perfusion.

Main Results:

  • Treatment rates for hypotension range from 16% to 98% in extremely preterm infants.
  • Current treatments for hypotension in preterm infants lack strong supporting evidence.
  • Assessing adequate tissue perfusion in neonates remains a significant clinical challenge.

Conclusions:

  • Evidence-based guidelines are crucial for managing hypotension and shock in preterm infants.
  • Treatment of hypotension in infants with adequate perfusion may be unnecessary and harmful.
  • Further research is essential to establish effective therapies for neonatal hypotension.

More Related Videos

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...